- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ceci Zak, Sanofi-Aventis US
The catalyst for innovation in the current environment is that people are living longer and the industry is not equipped to handle the significant burden that will place on the system.
Ceci Zak
Vice President, General Therapeutics Marketing, Sanofi-Aventis US
The catalyst for innovation in the current environment is that people are living longer and the industry is not equipped to handle the significant burden that will place on the system. This begs the question of how we can meet the future needs of the healthcare system—and how we can pay for it. We need to engage in the disruptive innovation that is critical to meet the evolving needs of the elderly.
In 10 years, I think the traditional pharma/bio model will have evolved from a treatment approach to one of providing total healthcare solutions, including preventative and diagnostic products, treatments, and maintenance support for patients. Thus, there will be a shift from our current target audiences (typically physicians) to the entire continuum of healthcare treaters.
I see my current roles as a senior-level businesswoman at Sanofi-Aventis and the president of the Healthcare Businesswomen's Association (HBA) as my great accomplishments. My role at HBA allows me to lead a board of directors that oversees numerous complex and successful events, such as WOTY (Woman of the Year), the Annual Leadership Conference, and other educational offerings provided by 14 chapters worldwide. During my presidential tenure at HBA, we are shoring up the strategic growth platform that will sustain the long-term viability of the organization. It's a wonderful way to give back!
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
